Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension study of idebenone in Friedreich's ataxia
2007-001646-40Phase 3Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of idebenone in Friedreich ataxia (FA), sponsored by Santhera Pharmaceuticals. Started Apr 2007; status: completed.
02
Drugs
idebenone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2007-001646-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001646-40.